Integrinexpression und integrinvermittelte VEGF-Produktion maligner Schilddrüsenzellen in vitro

Schilddrüsenkarzinome sind die häufigste maligne Erkrankung endokriner Organe. Als entscheidender Faktor für die Tumorprogression wurde die Fähigkeit der Schilddrüsenkarzinomzellen zur Angiogenese erkannt, die ihnen ein uneingeschränktes Wachstum und die Invasion des umgebenden Gewebes ermöglicht....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Amari, Tarik
Beteiligte: Zielke, Andreas (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Format: Dissertation
Sprache:Deutsch
Veröffentlicht: Philipps-Universität Marburg 2009
Operative Medizin
Schlagworte:
Online Zugang:PDF-Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

1. Self-regulation of growth in three dimensions.


2. Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J Cell Biol. 1988, 106(3):925-30.


3. Analysis of Integrin {beta}4 Expression in Human Breast Cancer: Association with Basal-like Tumors and Prognostic Significance.


4. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.


5. Factor XIII mediates adhesion of platelets to endothelial cells through alpha(v)beta(3) and glycoprotein IIb/IIIa integrins.


6. Claisse D, Martiny I, Chaqour B, Wegrowski Y, Petitfrere E, Schneider C, Haye B, Bellon G. Influence of transforming growth factor beta1 (TGF-beta1) on the behaviour of porcine thyroid epithelial cells in primary culture through thrombospondin-1 synthesis.


7. Ensinger CH, Obrist P, Bacher-Stier C, Mikuz G, Moncayo R, & Riccabona G. β1-integrin expression in papillary thyroid carcinoma Cancer Research 1998, 18: 33-40.


8. Silletti S, Cheresh D A A link between integrins and MMPs in angiogenesis Fibrinolysis and Proteolysis 1999, 13, No. 6:226-238.


9. Ruoslahti E, Reed JC Review: Anchorage Dependence, Integrins and Apoptosis Cell 1994, 77:577-478.


10. Angiogenesis promoted by vascular endothelian growth factor: Regulation through alpha1beta1 and alpha2beta1 integrins.


11. Antisense p53 decreases production of VEGF in follicular thyroid cancer cells.


12. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively.


13. Pierschbacher MD, Ruoslahti E Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature. 1984, 309(5963):30-3.


14. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.


15. Zielke A, Tezelman S, Jossart GH, Wong M, Siperstein AE, Duh QY, Clark OH Establishment of a highly differentiated thyroid cancer cell line of Hurthle cell origin. Thyroid. 1998, 8(6):475-83.


16. Clezardin P Recent insights into the role of integrins in cancer metastasis Cellular and Molecular Life Sciences 1998, Vol. 54, Issue 6:541-548.


17. Curr Cancer Drug Targets. 2006, 6(2):89-105.


18. Friedlander M, Brooks PC,Shaffer RW Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct α v integrins Science. 1995, 270(5241):1500-2.


19. Hoffmann S, Maschuw K, Hassan I, Reckzeh B, Wunderlich A, Lingelbach S, Zielke A. Differential pattern of integrin receptor expression in differentiated and anaplastic thyroid cancer cell lines. Thyroid. 2005, 15(9):1011-20.


20. Diminished expression of the alpha 5 beta 1 integrin (fibronectin receptor) by invasive clones of a human follicular thyroid cancer cell line.


21. Nermut MV, Green NM, Eason P, Yamada SS, and Yamada KM Electron microscopy and structural model of human fibronectin receptor EMBO J. 1988, 7(13):4093-9.


22. Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop.


23. Weaver, Valerie M, Roskelley, Calvin D Extracellular matrix: the central regulator of cell and tissue homeostasis Trends in Cell Biology, 1997, 7, Issue: 1:40-42.


24. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.


25. Fibroblast growth factors: at the heart of angiogenesis.


26. Vitale M, Matola T di, Fenzi G, Illario M, Rossi G Fibronectin is required to prevent thyroid cell apoptosis through an integrin-mediated adhesion mechanism J Clin Endocrinol Metab. 1998, 83(10):3673-80.


27. Trusilino L, Serini G, Cecchini G, Besati C, Ambesi-Impiombat FS, Marchisio PC, Filippi R Growth Factor-dependent Activation of αvβ3 integrin in Normal epithel cells: Implecation for tumor invasion J Cell Biol. 1998, 142(4):1145-56.


28. Literaturverzeichnis ___________________________________________________________________________________ _________________________________________________________________________________62 Ferrara N, Henzel WJ Pituitary follicular cells secrete a noval growth factor specific for vascular endothelial cells. BBRC 1989, 161:851-8.


29. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.


30. Yeh CH, Peng HC, Huang TF Cytokines Modulate Integrinα vβ3-Mediated Human Endothelial Cell Adhesion and Calcium Signaling Literaturverzeichnis ___________________________________________________________________________________ _________________________________________________________________________________67 Experimental Cell Research, 1999, 251, No. 1:57-66


31. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.


32. Literaturverzeichnis ___________________________________________________________________________________ _________________________________________________________________________________66 Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun. 1992, 187(3):1579-86.


33. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products.


34. Vitale M, Illario M,Di Matola T,Casamassima A,Fenzi G,Rossi G Integrin binding to immobilized collagen and fibronectin stimulates the proliferation of human thyroid cells in culture. Endocrinology. 1997, 138(4):1642-8.


35. Integrins α5β1, αvβ1, and αvβ6 Collaborate in Squamous Carcinoma Cell Spreading and Migration on Fibronectin Experimental Cell Research 2000, Vol. 255, No. 1:10-17.


36. Integrins: a family of cell surface receptors.


37. Integrins and signal transduction pathways: the road taken.


38. Eble JA, Haier J. Integrins in cancer treatment.


39. Dahlmann T, Grimelius L, Wallin G, Rubin K, Westermark K Integrins in thyroid tissue upregulation of α2β1 in anaplastic thyroid carcinoma European Journal of Endocrinology 1998, 138:104-112.


40. Setty S, Kim Y, Fields GB, Clegg DO, Wayner EA, Tsilibary EC. Interactions of type IV collagen and its domains with human mesangial cells.


41. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol. 1998, 153(5):1333-9.


42. Laminin-a glycoprotein from basement membranes.


43. Liotta LA Tumor invasion and metastases – role of the extracellular matrix Cancer Res. 1986, 46(1):1-7.


44. Timpl R. Macromolecular organization of basement membranes.


45. Yurchenco PD, Schittny JC Molecular architecture of basement membranes.


46. Ferrara N, Houl LM, Jackeman L, Leung DW Molekular and biolgical properties of the VEGD family of proteins Endocrin Rev. 1992, 13:18-32.


47. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.


48. Kelly T, Molony L, and Burridge K Purification of two smooth muscle glycoproteins related to integrin. Distribution in cultured chicken embryo fibroblasts J. Biol. Chem. 1987, 262: 17189-17199


49. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin.


50. Role of integrins in the attachment of metastatic follicular thyroid carcinoma cell lines to bone. Thyroid. 1998, 8(1):29-36.


51. Role of the αvβ3 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin Cancer Research 1992, 52:4499-4506.


52. Coppolino, Marc G, Dedhar, Shoukat Bi-directional signal transduction by integrin receptors The International Journal of Biochemistry and Cell Biology 2000, Vol 32, 2:171-188.


53. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.


54. Ruoslahti E Protein, Structure RGD and other recognition sequences for integrins.


55. FerraraN , Davis-Smyth T, The biology of vascular endothelial growth factor Endocrin Rev 1997, 18:4-25.


56. Warren BA and Shubik P The growth of blood suppply to melanoma transplants in the hamster cheek pouch Lab. Invest. 1966, 15:464-478.


57. Thomlinson RH, Grey LH The histological strukture of some human lung cancers and possible implications for radiotherapy Br J Cancer 1955, 9:539-49.


58. The laminins.


59. Thyroid stimulating hormon promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines Surgery 1996, 120(6):944-947.


60. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors.


61. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science. 1986, 232(4755):1250-3.


62. Greebblatt M and Shubik P Tumor angiogenesis: transfikter diffusion studies in the hamster by the transparent chamber technique J Natl.Cancer Inst. 1968, 41:111-124.


63. Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G, Fusco Persico M G Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PIGF) associated with malignancy in human tumors and cell lines Oncogene, 1995, 11:1569-1579.


64. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.


65. Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, Keshet E, Neufeld G., VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem. 1997, 272(11):7151-8.


66. Hynes RO Integrins: Versalyty Modulation, and Signaling in Cell Adhesion Cell 1992, Vol.69:11-25.


67. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983, 219(4587):983-5.


68. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors.


69. Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis.


70. Integrin signaling is critical for pathological angiogenesis.


71. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors.


72. Laminin receptor on human breast carcinoma cells.


73. Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.


74. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.